Figure 3.
Time on previous chronic renal replacement therapy, RRT in years stratified by outcome. Asymptomatic, patients on hemodialysis with asymptomatic shedding of SARS-CoV-2 RNA; outpatient, patients with COVID-19 treated as outpatients only; hospitalized, patients who were hospitalized but did not develop an acute respiratory distress syndrome (ARDS); survived ARDS, patients with ARDS followed by recovery and discharge; fatal ARDS, patients with ARDS followed by death. Each data point represents 1 single patient. Horizontal bars: median. Boxes: 25% to 75% interquartile range, IQR. Whiskers: 10% to 90% IQR. Statistical testing using ANOVA with Tuckey post-hoc analysis. Of note, patient HD 9 who developed nonfatal ARDS despite a very short duration of previous RRT of 0.6 years (left black dot under “Survived ARDS”) suffered from chronic asthma as a known non-renal risk factor for developing ARDS.